Innate Pharma (IPHA) Research & Development (2019 - 2026)
Innate Pharma's Research & Development was -$19.62 million in the quarter ended Jun 30, 2026, compared with -$23.23 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innate Pharma's Research & Development was -$149.17 million through Jun 30, 2026; for the year ended Dec 31, 2025, it was -$49.28 million.
- In earlier years, Research & Development was -$56.26 million in the year ended Dec 31, 2024, -$60.6 million in the year ended Dec 31, 2023, -$54.45 million in the year ended Dec 31, 2022 and -$53.77 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Research & Development in data going back to the quarter ended Jun 30, 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | -19.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.62 Mn |
| Dec 31, 2025 | -50.78 Mn |
| Jun 30, 2025 | -23.23 Mn |
| Dec 31, 2024 | -55.55 Mn |
| Jun 30, 2024 | -31.31 Mn |
| Dec 31, 2023 | -60.28 Mn |
| Jun 30, 2023 | -34.25 Mn |
| Dec 31, 2022 | -52.71 Mn |
| Jun 30, 2022 | -26.63 Mn |
| Dec 31, 2021 | -53.77 Mn |
| Jun 30, 2021 | -26.25 Mn |
| Dec 31, 2020 | -59.27 Mn |
| Jun 30, 2020 | -34.69 Mn |
| Dec 31, 2019 | -87.27 Mn |
| Jun 30, 2019 | -41.11 Mn |
API Access
Innate Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();